DEPLETION OF NEUTROPHILS BY FILTER DURING AORTOCORONARY BYPASS-SURGERY TRANSIENTLY IMPROVES POSTOPERATIVE CARDIORESPIRATORY STATUS

被引:48
作者
JOHNSON, D
THOMSON, D
MYCYK, T
BURBRIDGE, B
MAYERS, I
机构
[1] UNIV SASKATCHEWAN,DEPT ANESTHESIA,SASKATOON,SK S7N 0W0,CANADA
[2] UNIV SASKATCHEWAN,DEPT MED IMAGING,SASKATOON,SK S7N 0W0,CANADA
[3] UNIV SASKATCHEWAN,DEPT MED,SASKATOON,SK S7N 0W0,CANADA
[4] UNIV SASKATCHEWAN,DEPT SURG,SASKATOON,SK S7N 0W0,CANADA
关键词
CARDIOPULMONARY BYPASS; GRANULOCYTES; HEMODYNAMICS; INTRAPULMONARY SHUNT;
D O I
10.1378/chest.107.5.1253
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To determine whether inclusion of a leukocyte specific filter into the extracorporeal circuit during aortocoronary bypass surgery alters postoperative cardiopulmonary function. Design: Randomized, double-blinded control trial. Setting: Tertiary care hospital. Patients: Convenience sampling of patients undergoing elective aortocoronary bypass between October 1992 and June 1993. Interventions: A total of 32 patients were randomized to a leukocyte specific filter (n = 16) or to a standard blood filter (n = 16) during the surgical procedure. Measurements and results: White blood cell count in the standard filter group (12.2 +/- 3.6 10(9)/L) was higher (p = 0.047) than in the leukocyte filter group (9.9 +/- 2.6 10(9)/L) at 4 h postoperatively but counts were similar (p = 0.063) at 24 h (10.8 +/- 2.7 vs 8.9 +/- 2.8 10(9)/L, respectively), Leukocyte activation assessed by chemiluminescence was similar between groups at all measurement periods. We noted transient improvements (p < 0.05) in intrapulmonary shunt (19 +/- 50% vs 24 +/- 9%) and mean blood pressure (85 +/- 8 vs 76 +/- 9 mm Hg, respectively) in the leukocyte filter group compared with the standard filter group, respectively. Otherwise there were no differences noted between groups. Conclusions: Inclusion of a leukocyte filter during cardiopulmonary bypass caused transient cardiorespiratory improvement that was lost within 24 h and did not offer any significant clinical benefits.
引用
收藏
页码:1253 / 1259
页数:7
相关论文
共 22 条
[1]  
ABERG T, 1984, J THORAC CARDIOV SUR, V87, P99
[2]  
BANDO K, 1990, J THORAC CARDIOV SUR, V99, P873
[3]   PLATELET-LEUKOCYTE PLASMAPHERESIS ATTENUATES THE DELETERIOUS EFFECTS OF CARDIOPULMONARY BYPASS [J].
DAVIES, GG ;
WELLS, DG ;
MABEE, TM ;
SADLER, R ;
MELLING, NJ .
ANNALS OF THORACIC SURGERY, 1992, 53 (02) :274-277
[4]   RELEASE OF VASOACTIVE SUBSTANCES DURING CARDIOPULMONARY BYPASS [J].
DOWNING, SW ;
EDMUNDS, LH .
ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1236-1243
[5]  
ELGEBALY SA, 1992, J THORAC CARDIOV SUR, V103, P952
[6]  
ENGLER RL, 1983, AM J PATHOL, V111, P98
[7]   INTERLEUKIN-6 (IL-6) AS A MEDIATOR OF STUNNED MYOCARDIUM [J].
FINKEL, MS ;
HOFFMAN, RA ;
SHEN, L ;
ODDIS, CV ;
SIMMONS, RL ;
HATTLER, BG .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (13) :1231-1232
[8]  
GOURLAY T, 1992, Perfusion (London), V7, P131, DOI 10.1177/026765919200700209
[9]  
KIRKLIN J K, 1987, Blood Purification, V5, P168, DOI 10.1159/000169466